AroCell
AroCell's board of directors proposes to the AGM that the parent company change its name to IDL Diagnostics AB
The board proposes to the annual general meeting (AGM) that AroCell AB changes its name to IDL Diagnostics AB. The main purpose of the name change is to create a stronger connection to the diagnostics industry.
The board and management see several advantages with the proposed name change:
· It becomes clear that we are active in the field of diagnostics when we add "Diagnostics" to the company name.
· IDL Biotech is a well-known name for our partners, customers, clinics, and other stakeholders.
· A clear connection to IDL Biotech and its product portfolio is established, which today accounts for most of our revenue and operations.
The new name will serve as a collective name for all the company's operations and products, while clarifying the company's direction and providing a strong foundation for the company's continued growth.
"I see great value in highlighting IDL as a brand because it is a well-established name in the industry. It will be helpful in the growth journey that lies ahead for all the group's products," says Anders Hultman, CEO of AroCell.
| Datum | 2025-04-11, kl 09:00 |
| Källa | MFN |
SAVR är investeringsplattformen som utmanar branschen och gör det både enklare och roligare att investera. Betala aldrig för mycket! Alla aktier och ETF:er från 1 kr, och få upp till 50 % rabatt på alla fonder. Automatiskt courtage och samma enkla prismodell på alla marknader.